Literature DB >> 12074565

Membrane association of estrogen receptor alpha mediates estrogen effect on MAPK activation.

Zhenguo Zhang1, Bernhard Maier, Richard J Santen, Robert X-D Song.   

Abstract

Estrogen rapidly activates MAPK in many cell types but the mechanisms have not been fully understood. We previously demonstrated that 17-beta-estradiol (estradiol) rapidly induced membrane translocation of estrogen receptor alpha (ERalpha) and activated MAPK in MCF-7 breast cancer cells. This study further determines the cause and effect relationship between the presence of membrane ERalpha and MAPK activation. ERalpha with a membrane localization signal (HE241G-mem) was expressed and compared with the ones in nucleus (HEGO) or cytosol (HE241G) localization. Confocal microscopy showed that HE241G-mem was expressed in the cell membrane as well as in the cytosol in COS-1 cells. HE241G localized in the cytosol and HEGO in the nucleus. Functional studies showed that only membrane ERalpha, not cytosol and nuclear ones, responded to estradiol by inducing MAPK phosphorylation. HE241G-mem neither increased basal nor estradiol-induced ERE promoter activation, indicating no transcriptional action involved. Our data support the view that membrane-associated ERalpha is critical in estrogen-initiated MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074565     DOI: 10.1016/S0006-291X(02)00348-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Integration of the extranuclear and nuclear actions of estrogen.

Authors:  Ellis R Levin
Journal:  Mol Endocrinol       Date:  2005-02-10

Review 2.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  17β-estradiol Induces MMP-9 and MMP-13 in TMJ Fibrochondrocytes via Estrogen Receptor α.

Authors:  N Ahmad; S Chen; W Wang; S Kapila
Journal:  J Dent Res       Date:  2018-04-05       Impact factor: 6.116

4.  Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms.

Authors:  Katherine A Burns; Yin Li; Yukitomo Arao; Robert M Petrovich; Kenneth S Korach
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 5.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

6.  Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor.

Authors:  Fuzhong F Zheng; Ray-Chang Wu; Carolyn L Smith; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 7.  Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Front Neuroendocrinol       Date:  2012-10-02       Impact factor: 8.606

Review 8.  Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation.

Authors:  Qun Zhou; Patrick G Shaw; Nancy E Davidson
Journal:  Endocr Relat Cancer       Date:  2009-02-10       Impact factor: 5.678

9.  ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.

Authors:  Jing-Shan Tong; Qing-Hua Zhang; Zhen-Bo Wang; Sen Li; Cai-Rong Yang; Xue-Qi Fu; Yi Hou; Zhao-Yi Wang; Jun Sheng; Qing-Yuan Sun
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

10.  BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer.

Authors:  Mahnaz Razandi; Ali Pedram; Eliot M Rosen; Ellis R Levin
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.